ISPO

Novel Molecular Therapies

Farnesyltransferase inhibitors

J. Gibbs Ph.D., C. Buser Ph.D., J. deSolms Ph.D., C. Dinsmore Ph.D., S. Graham Ph.D., G. Hartman Ph.D., D. Heimbrook Ph.D., H. Huber Ph.D., K. Koblan Ph.D., R. Lobell Ph.D., C. Omer Ph.D., S. Stirdivant Ph.D., T. Williams Ph.D., N.E. Kohl Ph.D.,

Telomerase as a target for anticancer therapy

Jerry W. Shay

Antiangiogenesis

Adriana Albini, Francesca Tosetti, Ulrich Pfeffer, Davide Bisacchi, Silvio De Flora and Nicoletta Ferrari

Novel actions of inhibitors of dna topoisomerase i

William T Beck, PhD,Yin-Yuan Mo, PhD, P L Rachel , BS Rajiv Patel1

Differentiation therapy of human leukemia

L Degos, MD